{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T15:27:03Z","timestamp":1787498823694,"version":"build-2736575974"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,14]],"date-time":"2025-03-14T00:00:00Z","timestamp":1741910400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004328","name":"Genentech Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004328","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajo.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.ajo.2025.03.021","type":"journal-article","created":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T20:43:51Z","timestamp":1741898631000},"page":"14-26","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Phase 2 Study of the Anti-High Temperature Requirement A1 (HtrA1) Fab Galegenimab (FHTR2163) in Geographic Atrophy Secondary to Age-Related Macular Degeneration"],"prefix":"10.1016","volume":"275","author":[{"given":"David A.","family":"Eichenbaum","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7850-8515","authenticated-orcid":false,"given":"Nancy","family":"Holekamp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arshad M.","family":"Khanani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dante","family":"Pieramici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vrinda","family":"Hershberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7467-9947","authenticated-orcid":false,"given":"Veeral","family":"Sheth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flavia","family":"Brunstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2477-6906","authenticated-orcid":false,"given":"Yixuan","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9393-0017","authenticated-orcid":false,"given":"Vahan B.","family":"Indjeian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4120-7828","authenticated-orcid":false,"given":"Randall","family":"Dere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauricio","family":"Maia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2800-7322","authenticated-orcid":false,"given":"Joy C.","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7020-037X","authenticated-orcid":false,"given":"Simon S.","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3787-2510","authenticated-orcid":false,"given":"Brian","family":"Yaspan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey R.","family":"Willis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry","family":"Wiley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phillip","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ajo.2025.03.021_bib0001","first-page":"1","article-title":"Recent developments in the management of age-related macular degeneration","volume":"130","author":"Holz","year":"2020","journal-title":"J Clin Inv"},{"issue":"3","key":"10.1016\/j.ajo.2025.03.021_bib0002","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.ophtha.2017.08.038","article-title":"The progression of geographic atrophy secondary to age-related macular degeneration","volume":"125","author":"Fleckenstein","year":"2018","journal-title":"Ophthalmology"},{"issue":"3","key":"10.1016\/j.ajo.2025.03.021_bib0003","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.ophtha.2011.09.027","article-title":"Age and gender variations in age-related macular degeneration prevalence in populations of European ancestry: a meta-analysis","volume":"119","author":"Rudnicka","year":"2012","journal-title":"Ophthalmology"},{"issue":"2","key":"10.1016\/j.ajo.2025.03.021_bib0004","doi-asserted-by":"crossref","first-page":"e106","DOI":"10.1016\/S2214-109X(13)70145-1","article-title":"Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis","volume":"2","author":"Wong","year":"2014","journal-title":"Lancet Glob Health"},{"issue":"10411","key":"10.1016\/j.ajo.2025.03.021_bib0005","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1016\/S0140-6736(23)01583-0","article-title":"Efficacy and safety of avacincaptad pegol in patients with geographic atrophy (GATHER2): 12-month results from a randomised, double-masked, phase 3 trial","volume":"402","author":"Khanani","year":"2023","journal-title":"Lancet"},{"issue":"10411","key":"10.1016\/j.ajo.2025.03.021_bib0006","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1016\/S0140-6736(23)01520-9","article-title":"Pegcetacoplan for the treatment of geographic atrophy secondary to age-related macular degeneration (OAKS and DERBY): two multicentre, randomised, double-masked, sham-controlled, phase 3 trials","volume":"402","author":"Heier","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.ajo.2025.03.021_bib0007","doi-asserted-by":"crossref","first-page":"68292","DOI":"10.1016\/S0002-9394(01)01214-4","article-title":"Age-related maculopathy: an expanded genome wide scan with evidence of susceptibility loci within the 1q31 and 17q25 regions","volume":"132","author":"Weeks","year":"2001","journal-title":"Am J Ophthal"},{"key":"10.1016\/j.ajo.2025.03.021_bib0008","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1038\/ng.3448","article-title":"A large genome-wide association study of age-related macular degeneration highlights contributions of rare and common variants","volume":"48","author":"Fritsche","year":"2016","journal-title":"Nat Genet"},{"key":"10.1016\/j.ajo.2025.03.021_bib0009","doi-asserted-by":"crossref","DOI":"10.1016\/j.preteyeres.2022.101159","article-title":"Exploring the contribution of ARMS2 and HTRA1 genetic risk factors in age-related macular degeneration","volume":"97","author":"Pan","year":"2023","journal-title":"Prog Retin Eye Res"},{"key":"10.1016\/j.ajo.2025.03.021_bib0010","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/S1097-2765(02)00658-5","article-title":"The HtrA family of proteases: review implications for protein composition and cell fate","volume":"10","author":"Clausen","year":"2002","journal-title":"Mol Cell"},{"key":"10.1016\/j.ajo.2025.03.021_bib0011","doi-asserted-by":"crossref","first-page":"61249","DOI":"10.1074\/jbc.M500361200","article-title":"The role of human HtrA1 in arthritic disease","volume":"281","author":"Grau","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ajo.2025.03.021_bib0012","doi-asserted-by":"crossref","first-page":"e12710","DOI":"10.1111\/acel.12710","article-title":"HTRA1, an age-related macular degeneration protease, processes extracellular matrix pro- teins EFEMP1 and TSP1","volume":"17","author":"Lin","year":"2018","journal-title":"Aging Cell"},{"issue":"18","key":"10.1016\/j.ajo.2025.03.021_bib0013","doi-asserted-by":"crossref","first-page":"9952","DOI":"10.1073\/pnas.1917608117","article-title":"Development of a therapeutic anti-HtrA1 antibody and the identification of DKK3 as a pharmacodynamic biomarker in geographic atrophy","volume":"117","author":"Tom","year":"2020","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.ajo.2025.03.021_bib0014","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1102853108","article-title":"Increased expression of multifunctional serine protease, HTRA1, in retinal pigment epithelium induces polypoidal choroidal vasculopathy in mice","volume":"108","author":"Jones","year":"2011","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.ajo.2025.03.021_bib0015","doi-asserted-by":"crossref","DOI":"10.1167\/iovs.13-13111","article-title":"Angiographic features of transgenic mice with increased expression of human serine protease HTRA1 in retinal pigment epithelium","volume":"55","author":"Kumar","year":"2014","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ajo.2025.03.021_bib0016","doi-asserted-by":"crossref","first-page":"e22959","DOI":"10.1371\/journal.pone.0022959","article-title":"Overexpression of HTRA1 leads to ultrastructural changes in the elastic layer of Bruch's membrane via cleavage of extracellular matrix components","volume":"6","author":"Vierkotten","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.ajo.2025.03.021_bib0017","doi-asserted-by":"crossref","first-page":"98992","DOI":"10.1126\/science.1133807","article-title":"HTRA1 promoter polymorphism in wet age-related macular degeneration","volume":"314","author":"DeWan","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.ajo.2025.03.021_bib0018","doi-asserted-by":"crossref","first-page":"9923","DOI":"10.1126\/science.1133811","article-title":"A variant of the HTRA1 gene increases susceptibility to age-related macular degeneration","volume":"314","author":"Yang","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.ajo.2025.03.021_bib0019","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1016\/j.celrep.2019.12.082","article-title":"Integration of eQTL and a single-cell atlas in the human eye identifies causal genes for age-related macular degeneration","volume":"30","author":"Orozco","year":"2020","journal-title":"Cell Rep"},{"issue":"2","key":"10.1016\/j.ajo.2025.03.021_bib0020","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1042\/BJ20150601","article-title":"The trimeric serine protease HtrA1 forms a cage-like inhibition complex with an anti-HtrA1 antibody","volume":"472","author":"Ciferri","year":"2015","journal-title":"Biochem J"},{"key":"10.1016\/j.ajo.2025.03.021_bib0021","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ajo.2021.06.017","article-title":"Phase 1 study of the anti-HtrA1 antibody-binding fragment FHTR2163 in geographic atrophy secondary to age-related macular degeneration","volume":"232","author":"Khanani","year":"2021","journal-title":"Am J Ophthalmol"},{"issue":"3","key":"10.1016\/j.ajo.2025.03.021_bib0022","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1177\/0192623320976095","article-title":"Nonclinical safety assessment of FHTR2163, an antigen-binding fragment against HTRA1 for the treatment of geographic atrophy","volume":"49","author":"Dere","year":"2021","journal-title":"Toxicol Pathol"},{"key":"10.1016\/j.ajo.2025.03.021_bib0023","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1016\/j.ophtha.2021.02.025","article-title":"Characterizing new-onset exudation in the randomized phase 2 FILLY trial of complement inhibitor pegcetacoplan for geographic atrophy","volume":"128","author":"Wykoff","year":"2021","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2025.03.021_bib0024","doi-asserted-by":"crossref","first-page":"3551","DOI":"10.1038\/s41433-023-02497-w","article-title":"Avacincaptad pegol for geographic atrophy secondary to age-related macular degeneration: 18-month findings from the GATHER1 trial","volume":"37","author":"Patel","year":"2023","journal-title":"Eye"},{"issue":"2","key":"10.1016\/j.ajo.2025.03.021_bib0025","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.jstrokecerebrovasdis.2010.11.008","article-title":"Cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencephalopathy (CARASIL): from discovery to gene identification","volume":"20","author":"Fukutake","year":"2011","journal-title":"J Stroke Cerebrovasc Dis"},{"issue":"17","key":"10.1016\/j.ajo.2025.03.021_bib0026","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1056\/NEJMoa0801560","article-title":"Association of HTRA1 mutations and familial ischemic cerebral small-vessel disease","volume":"360","author":"Hara","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajo.2025.03.021_bib0027","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1093\/hmg\/ddy002","article-title":"Genome-wide analysis of disease progression in age-related macular degeneration","volume":"27","author":"Yan","year":"2018","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.ajo.2025.03.021_bib0028","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.4161\/cc.6.9.4157","article-title":"HTRA1 variant confers similar risks to geographic atrophy and neovascular age-related macular degeneration","volume":"6","author":"Cameron","year":"2007","journal-title":"Cell Cycle"},{"key":"10.1016\/j.ajo.2025.03.021_bib0029","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1016\/j.ophtha.2009.12.012","article-title":"Progression of geographic atrophy and genotype in age-related macular degeneration","volume":"117","author":"Klein","year":"2010","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2025.03.021_bib0030","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1167\/iovs.16-20922","article-title":"HTRA1 and TGF-beta1 concentrations in the aqueous humor of patients with neovascular age-related macular degeneration","volume":"58","author":"Tosi","year":"2017","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"30","key":"10.1016\/j.ajo.2025.03.021_bib0031","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2103617118","article-title":"Chromosome 10q26-driven age-related macular degeneration is associated with reduced levels of HTRA1 in human retinal pigment epithelium","volume":"118","author":"Williams","year":"2021","journal-title":"Proc Natl Acad Sci"},{"issue":"12","key":"10.1016\/j.ajo.2025.03.021_bib0032","doi-asserted-by":"crossref","first-page":"2729","DOI":"10.1016\/j.ajpath.2018.08.012","article-title":"High-temperature requirement A 1 causes photoreceptor cell death in zebrafish disease models","volume":"188","author":"Oura","year":"2018","journal-title":"Am J Pathol"},{"issue":"10","key":"10.1016\/j.ajo.2025.03.021_bib0033","doi-asserted-by":"crossref","first-page":"6514","DOI":"10.1167\/iovs.14-14453","article-title":"Overexpression of HtrA1 and exposure to mainstream cigarette smoke leads to choroidal neovascularization and subretinal deposits in aged mice","volume":"55","author":"Nakayama","year":"2014","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ajo.2025.03.021_bib0034","doi-asserted-by":"crossref","first-page":"545","DOI":"10.3389\/fneur.2020.00545","article-title":"HTRA1-related cerebral small vessel disease: a review of the literature","volume":"11","author":"Uemura","year":"2020","journal-title":"Front Neurol"}],"container-title":["American Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939425001321?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939425001321?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,3]],"date-time":"2026-05-03T03:55:53Z","timestamp":1777780553000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002939425001321"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":34,"alternative-id":["S0002939425001321"],"URL":"https:\/\/doi.org\/10.1016\/j.ajo.2025.03.021","relation":{},"ISSN":["0002-9394"],"issn-type":[{"value":"0002-9394","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Phase 2 Study of the Anti-High Temperature Requirement A1 (HtrA1) Fab Galegenimab (FHTR2163) in Geographic Atrophy Secondary to Age-Related Macular Degeneration","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajo.2025.03.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}